Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Gynaecology
  4. Gynaecology guidelines
  5. Back
  6. Guidelines A-Z (all Gynaecology guidelines)
  7. Female genital cosmetic surgery, Gynaecology (626)
Important: please update your RDS app to version 4.7.3

Welcome to the March 2025 update from the RDS team

1.     RDS issues - resolutions

1.1 Stability issues - Tactuum implemented a fix on 24th March which we believe has finally addressed the stability issues experienced over recent weeks.  The issue seems to have been related to the new “Tool export” function making repeated calls for content when new toolkit nodes were opened in Umbraco. No outages have been reported since then, and no performance issues in the logs, so fingers crossed this is now resolved.

1.2 Toolkit URL redirects failing– these were restored manually for the antimicrobial calculators on the 13th March when the issue occurred, and by 15th March for the remainder. The root cause was traced to adding a new hostname for an app migrated from another health board and made live that day. This led to the content management system automatically creating internal duplicate redirects, reaching the maximum number of permitted redirects and most redirects therefore ceasing to function.

This issue should not happen again because:

  • All old apps are now fully migrated to RDS. The large number of migrations has contributed to the high number of automated redirects.
  • If there is any need to change hostnames in future, Tactuum will immediately check for duplicates.

1.3 Gentamicin calculators – Incidents have been reported incidents of people accessing the wrong gentamicin calculator for their health board.  This occurs when clinicians are searching for the gentamicin calculator via an online search engine - e.g. Google - rather than via the health board directed policy route. When accessed via an external search engine, the calculator results are not listed by health board, and the start page for the calculator does not make it clearly visible which health board calculator has been selected.

The Scottish Antimicrobial Prescribing Group has asked health boards to provide targeted communication and education to ensure that clinicians know how to access their health board antimicrobial calculators via the RDS, local Intranet or other local policy route. In terms of RDS amendments, it is not currently possible to change the internet search output, so the following changes are now in progress:

  • The health board name will now be displayed within the calculator and it will be made clear which boards are using the ‘Hartford’ (7mg/kg) higher dose calculator
  • Warning text will be added to the calculator to advise that more than one calculator is in use in NHS Scotland and that clinicians should ensure they access the correct one for their health board. A link to the Right Decision Service list of health board antimicrobial prescribing toolkits will be included with the warning text. Users can then access the correct calculator for their Board via the appropriate toolkit.

We would encourage all editors and users to use the Help and Support standard operating procedure and the Editors’ Teams channel to highlight issues, even if you think they may be temporary or already noted. This helps the RDS team to get a full picture of concerns and issues across the service.

 

2.     New RDS presentation – RDS supporting the patient journey

A new presentation illustrating how RDS supports all partners in the patient journey – multiple disciplines across secondary, primary, community and social care settings – as well as patients and carers through self-management and shared decision-making tools – is now available. You will find it in the Promotion and presentation resources for editors section of the Learning and support toolkit.

3.     User guides

A new user guide is now available in the Guidance and tips section of Resources for providers within the Learning and Support area, explaining how to embed content from Google Calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream and Jotforms into RDS pages. A webinar for editors on using this new functionality is scheduled for 1 May 3-4 pm (booking information below.)

A new checklist to support editors in making all the checks required before making a new toolkit live is now available at the foot of the “Request a new toolkit” standard operating procedure. Completing this checklist is not a mandatory part of the governance process, but we would encourage you to use it to make sure all the critical issues are covered at point of launch – including organisational tags, use of Alias URLs and editorial information.

4.Training sessions for RDS editors

Introductory webinars for RDS editors will take place on:

  • Tuesday 29th April 4-5 pm
  • Thursday 1st May 4-5 pm

Special webinar for RDS editors – 1 May 3-4 pm

This webinar will cover:

  1. a) Use of the new left hand navigation option for RDS toolkits.
  2. b) Integration into RDS pages of content from external sources, including Google Calendar, Google Maps and simple Jotforms calculators.

Running usage statistics reports using Google analytics

  • Wednesday 23rd April 2pm-3pm
  • Thursday 22nd May 2pm-3pm

To book a place on any of these webinars, please contact Olivia.graham@nhs.scot providing your name, role, organisation, title and date of the webinar you wish to attend.

5.New RDS toolkits

The following toolkits were launched during March 2025:

SIGN guideline - Prevention and remission of type 2 diabetes

Valproate – easy read version for people with learning disabilities (Scottish Government Medicines Division)

Obstetrics and gynaecology induction toolkit (NHS Lothian) – password-protected, in pilot stage.

Oral care for care home and care at home services (Public Health Scotland)

Postural care in care homes (NHS Lothian)

Quit Your Way Pregnancy Service (NHS GGC)

 

6.New RDS developments

Release of the redesign of RDS search and browse, archiving and version control functionality, and editing capability for shared content, is now provisionally scheduled for early June.

The Scottish Government Realistic Medicine Policy team is leading development of a national approach to implementation of Patient-Reported Outcome Measures (PROMs) as a key objective within the Value Based Health and Care Action Plan. The Right Decision Service has been commissioned to deliver an initial version of a platform for issuing PROMs questionnaires to patients, making the PROMs reports available from patient record systems, and providing an analytics dashboard to compare outcomes across services.  This work is now underway and we will keep you updated on progress.

The RDS team has supported Scottish Government Effective Prescribing and Therapeutics Division, in partnership with Northern Ireland and Republic of Ireland, in a successful bid for EU funding to test develop, implement and assess new integrated care pathways for polypharmacy, including pharmacogenomics. As part of this project, the RDS will be working with NHS Tayside to test extending the current polypharmacy RDS decision support in the Vision primary care electronic health record system to include pharmacogenomics decision support.

7. Implementation projects

We have just completed a series of three workshops consulting on proposed improvements to the Being a partner in my care: Realistic Medicine together app, following piloting on 10 sites in late 2024. This app has been commissioned by Scottish Government Realistic Medicine to support patients and citizens to become active partners in shared decision-making and encouraging personalised care based on outcomes that matter to the person. We are keen to gather more feedback on this app. Please forward any feedback to ann.wales3@nhs.scot

 

 

Female genital cosmetic surgery, Gynaecology (626)

Warning

Objectives

To provide guidance to health professionals involved in the care of those requesting surgery to change the appearance of their vulva

Audience

Healthcare professionals working in primary and secondary care involved in the care of individuals with a vulva

Please report any inaccuracies or issues with this guideline using our online form

Female genital cosmetic surgery (FGCS) describes a group of surgical procedures designed to change healthy female genitalia for perceived improvement in cosmetic appearance (1).  Labiaplasty is the most common FGCS procedure, and describes a surgical procedure involving partial removal and reduction in the size of the labia minora.  Commonly, there will be reduction bilaterally to both labia minora, but may also be carried out to reduce asymmetry when one is longer than the other. Removal or reduction of the clitoral hood may also be performed ‘hoodectomy’.

Other FGCS procedures include vaginaplasty, liposuction of the labia majora, fat injection to the labia minora and mons pubis, hymenal reconstruction, hair transplantation, and laser therapy. (2)

The reasons that FGCS are requested are often to alleviate perceived functional discomfort, improve appearance and increase self-esteem.  It is thought there is pressure on those with a vulva to appear ‘neater’, with a younger, pre-pubescent look being more desirable (3).  Vulvodynia (pain without a clear identifiable cause) is not an indication for FGCS.

The size range and symmetry of the adult labia shows a wide variation. It is often useful to support a patient presenting with concerns and discuss the range of ‘normality’. The RCOG ethical paper opinion outlines clinicians have a duty of care to provide this information (1).

It is also essential to discuss the anatomy of the vulva including demonstrating the mons pubis, labia majora, minora, clitoris and hood, urethra, vaginal vestibule, perineum and perianal areas (1). A recent study suggesting up to 40% of patients are unable to correctly identify genital structures, with implications for health care seeking and shared decision making (4).

The implications of FGCS can stem from unrealistic expectations, with many women being disappointed with the outcome.  Surgery can be marketed as helping urinary function and sexual functioning, however there is a lack of high quality evidence.

Additionally, there can be scarring affecting functioning and appearance.  Importantly, there can be issues with residual pain, change in sensation and altered sexual functioning.  In the short term there can be complications with wound dehiscence (up to 30%) and infection (1).

Overall, FGCS should be considered as medically non-essential surgery.  The RCOG recommends   that FGCS should not be undertaken within the NHS unless it is medically indicated, and should not normally be offered to individuals below 18 years of age, due to continued anatomical development during puberty. 

All surgeons who undertake FGCS must be aware that the procedure may be prohibited unless it is necessary for the patient’s physical or mental health, and they must take appropriate measures to ensure compliance with the FGM Acts. (5)

As such, within Greater Glasgow and Clyde Health Board, FGCS is not offered as a cosmetic only procedure.

Exceptions may include where surgery is medically necessary and secondary to another underlying medical conditions.  Examples may include

  • Anatomical Implications secondary to genital Cancer
  • Significant congenital malformations e.g. secondary to congenital adrenal hyperplasia
  • Repair after significant trauma, e.g. secondary to severe adhesions from Lichen Sclerosus

Referrals should initially be made to general gynaecology.

Links to educational and supportive information as above should be made available to patients and those working in primary care prior to review in clinic.

The RCOG recognises that often, the ‘desire for labial reduction is a type of displacement for other forms of anxiety or lack of feelings of self-worth, and thus whether counselling may be more appropriate than surgery’.  To this end, psychology referral should be considered in primary care prior to referral to gynaecology.

The patient may then be seen by any gynaecologist. If that gynaecologist is of the opinion that there are no abnormalities of the external genitalia, and there is no evidence of a dermatosis requiring treatment, then the patient should be reassured and discharged from gynaecology.

Women should be directed to the information above if they have not already accessed.  Advice should be regarding general vulval care.

Where surgery may be required (see indications above), an opinion and/or input from the Plastic Surgery Service may be required. Where there are complications arising from previous FGCS, plastic surgery should be involved and consideration given to clinical photography as part of clinical notes.

Editorial Information

Last reviewed: 14/11/2023

Next review date: 31/10/2027

Author(s): Claire Higgins.

Version: 2

Approved By: Gynaecology Clinical Governance Group

Document Id: 626